Raras
Buscar doenças, sintomas, genes...
Hemiplegia alternante da infância
ORPHA:2131CID-10 · G98CID-11 · MB53.0DOENÇA RARA

Uma condição neurológica rara caracterizada por crises repetidas de paralisia em um lado do corpo e distúrbios súbitos, que também vêm com um atraso persistente no desenvolvimento e dificuldades de aprendizado e raciocínio.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma condição neurológica rara caracterizada por crises repetidas de paralisia em um lado do corpo e distúrbios súbitos, que também vêm com um atraso persistente no desenvolvimento e dificuldades de aprendizado e raciocínio.

Publicações científicas
365 artigos
Último publicado: 2026 Apr 8
Medicamentos
2 registrados
SODIUM OXYBATE, OXYBATE

Tem tratamento?

2 medicamentos registrados
Ver detalhes, fases e interações →
SODIUM OXYBATEOXYBATE

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G98
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
18 sintomas
🫃
Digestivo
10 sintomas
📏
Crescimento
8 sintomas
🫘
Rins
4 sintomas
👁️
Olhos
4 sintomas
🧬
Pele e cabelo
3 sintomas

+ 48 sintomas em outras categorias

Características mais comuns

90%prev.
Anormalidade do trato gastrointestinal
Muito frequente (99-80%)
90%prev.
Hemiplegia episódica
Muito frequente (99-80%)
90%prev.
Dismotilidade gastrointestinal
Muito frequente (99-80%)
55%prev.
Anorexia
Frequente (79-30%)
55%prev.
Rubor
Frequente (79-30%)
55%prev.
Esotropia
Frequente (79-30%)
103sintomas
Muito frequente (3)
Frequente (24)
Ocasional (34)
Muito raro (4)
Sem dados (38)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 103 características clínicas mais associadas, ordenadas por frequência.

Anormalidade do trato gastrointestinalAbnormality of the gastrointestinal tract
Muito frequente (99-80%)90%
Hemiplegia episódicaEpisodic hemiplegia
Muito frequente (99-80%)90%
Dismotilidade gastrointestinalGastrointestinal dysmotility
Muito frequente (99-80%)90%
Anorexia
Frequente (79-30%)55%
RuborFlushing
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico365PubMed
Últimos 10 anos200publicações
Pico202130 papers
Linha do tempo
2026Hoje · 2026🧪 2008Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

9 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

SLC1A3Excitatory amino acid transporter 1Candidate gene tested inTolerante
FUNÇÃO

Sodium-dependent, high-affinity amino acid transporter that mediates the uptake of L-glutamate and also L-aspartate and D-aspartate (PubMed:20477940, PubMed:26690923, PubMed:28032905, PubMed:28424515, PubMed:7521911, PubMed:8123008). Functions as a symporter that transports one amino acid molecule together with two or three Na(+) ions and one proton, in parallel with the counter-transport of one K(+) ion (PubMed:20477940). Mediates Cl(-) flux that is not coupled to amino acid transport; this avo

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Astrocytic Glutamate-Glutamine Uptake And MetabolismGlutamate Neurotransmitter Release CycleSLC-mediated transport of amino acids
MECANISMO DE DOENÇA

Episodic ataxia 6

A disorder characterized by episodic ataxia, seizures, migraine and alternating hemiplegia.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
316.8 TPM
Brain Anterior cingulate cortex BA24
306.0 TPM
Córtex cerebral
299.4 TPM
Brain Frontal Cortex BA9
286.9 TPM
Brain Nucleus accumbens basal ganglia
269.0 TPM
OUTRAS DOENÇAS (2)
episodic ataxia type 6alternating hemiplegia of childhood
HGNC:10941UniProt:P43003
NR0B1Nuclear receptor subfamily 0 group B member 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Nuclear receptor that lacks a DNA-binding domain and acts as a corepressor that inhibits the transcriptional activity of other nuclear receptors through heterodimeric interactions (PubMed:12482977, PubMed:32433991). Component of a cascade required for the development of the hypothalamic-pituitary-adrenal-gonadal axis (PubMed:7990953, PubMed:8675564). May also have a role in the development of the embryo and in the maintenance of embryonic stem cell pluripotency (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Adrenal hypoplasia, congenital

A disorder of adrenal gland development characterized by absence of the permanent zone of the adrenal cortex, structural disorganization of the adrenal glands, adrenal insufficiency and profound hormonal deficiencies. AHC patients manifest primary adrenal failure usually in early infancy, and hypogonadotropic hypogonadism leading to absent or incomplete sexual maturation. AHC can be inherited in an X-linked or autosomal recessive pattern.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
42.5 TPM
Testículo
39.1 TPM
Ovário
4.8 TPM
Pituitária
3.5 TPM
Cervix Ectocervix
2.9 TPM
OUTRAS DOENÇAS (5)
X-linked adrenal hypoplasia congenita46,XY sex reversal 246,XY complete gonadal dysgenesis46,XX testicular disorder of sex development
HGNC:7960UniProt:P51843
SLC2A1Solute carrier family 2, facilitated glucose transporter member 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Facilitative glucose transporter, which is responsible for constitutive or basal glucose uptake (PubMed:10227690, PubMed:10954735, PubMed:18245775, PubMed:19449892, PubMed:25982116, PubMed:27078104, PubMed:32860739). Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses (PubMed:18245775, PubMed:19449892). Most important energy carrier of the brain: present at the blood-brain barrier and assures the energy-independent, facilitative trans

LOCALIZAÇÃO

Cell membraneMelanosomePhotoreceptor inner segment

VIAS BIOLÓGICAS (3)
Vitamin C (ascorbate) metabolismCellular hexose transportRegulation of insulin secretion
MECANISMO DE DOENÇA

GLUT1 deficiency syndrome 1

A neurologic disorder showing wide phenotypic variability. The most severe 'classic' phenotype comprises infantile-onset epileptic encephalopathy associated with delayed development, acquired microcephaly, motor incoordination, and spasticity. Onset of seizures, usually characterized by apneic episodes, staring spells, and episodic eye movements, occurs within the first 4 months of life. Other paroxysmal findings include intermittent ataxia, confusion, lethargy, sleep disturbance, and headache. Varying degrees of cognitive impairment can occur, ranging from learning disabilities to severe intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
703.8 TPM
Skin Not Sun Exposed Suprapubic
272.6 TPM
Skin Sun Exposed Lower leg
265.8 TPM
Vagina
176.1 TPM
Esôfago - Mucosa
154.8 TPM
OUTRAS DOENÇAS (8)
childhood onset GLUT1 deficiency syndrome 2hereditary cryohydrocytosis with reduced stomatindystonia 9encephalopathy due to GLUT1 deficiency
HGNC:11005UniProt:P11166
MT-TL2Disease-causing germline mutation(s) inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (3)
G alpha (i) signalling eventsFormyl peptide receptors bind formyl peptides and many other ligandsG alpha (q) signalling events
OUTRAS DOENÇAS (3)
mitochondrial diseasematernally-inherited progressive external ophthalmoplegiaalternating hemiplegia of childhood
HGNC:7491
ATP1A2Sodium/potassium-transporting ATPase subunit alpha-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium, providing the energy for active transport of various nutrients

LOCALIZAÇÃO

MembraneCell membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Migraine, familial hemiplegic, 2

A subtype of migraine with aura associated with hemiparesis in some families. Migraine is a disabling symptom complex of periodic headaches, usually temporal and unilateral. Headaches are often accompanied by irritability, nausea, vomiting and photophobia, preceded by constriction of the cranial arteries. Migraine with aura is characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred vision, hallucinations, vertigo, numbness and difficulty in concentrating and speaking.

OUTRAS DOENÇAS (7)
migraine, familial hemiplegic, 2fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic faciesdevelopmental and epileptic encephalopathy 98alternating hemiplegia of childhood 1
HGNC:800UniProt:P50993
ATP1A3Sodium/potassium-transporting ATPase subunit alpha-3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisIon transport by P-type ATPasesPotential therapeutics for SARS
MECANISMO DE DOENÇA

Dystonia 12

An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.

OUTRAS DOENÇAS (6)
developmental and epileptic encephalopathy 99cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromedystonia 12alternating hemiplegia of childhood 2
HGNC:801UniProt:P13637
SCN2ASodium channel protein type 2 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient (PubMed:1325650, PubMed:17021166, PubMed:28256214, PubMed:29844171). Implicated in the regulation of hippocampal replay occurring within sharp wave ripples (SPW-R) important for memory (By simi

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Seizures, benign familial infantile, 3

A form of benign familial infantile epilepsy, a neurologic disorder characterized by afebrile seizures occurring in clusters during the first year of life, without neurologic sequelae. BFIS3 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
70.3 TPM
Cerebelo
65.2 TPM
Brain Frontal Cortex BA9
19.3 TPM
Córtex cerebral
11.5 TPM
Brain Nucleus accumbens basal ganglia
9.1 TPM
OUTRAS DOENÇAS (10)
seizures, benign familial infantile, 3episodic ataxia, type 9developmental and epileptic encephalopathy, 11complex neurodevelopmental disorder
HGNC:10588UniProt:Q99250
CACNA1AVoltage-dependent P/Q-type calcium channel subunit alpha-1ACandidate gene tested inAltamente restrito
FUNÇÃO

Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1A gives rise to P and/or Q-type calcium currents. P/Q-type calcium channels belong to the 'high-voltage activated' (HVA) group and are specifically blocked by the spider omega-agatoxin-IVA

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Presynaptic depolarization and calcium channel openingRegulation of insulin secretion
MECANISMO DE DOENÇA

Spinocerebellar ataxia 6

Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA6 is an autosomal dominant cerebellar ataxia (ADCA), mainly caused by expansion of a CAG repeat in the coding region of CACNA1A. There seems to be a correlation between the repeat number and earlier onset of the disorder.

OUTRAS DOENÇAS (9)
migraine, familial hemiplegic, 1episodic ataxia type 2developmental and epileptic encephalopathy, 42spinocerebellar ataxia type 6
HGNC:1388UniProt:O00555
RHOBTB2Rho-related BTB domain-containing protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulator of cell proliferation and apoptosis (PubMed:21801820). It likely functions as a substrate-adapter that recruits key substrates, e.g. MSI2, to CUL3-based ubiquitin ligase complexes for degradation (PubMed:15107402, PubMed:27941885). Required for MSI2 ubiquitination and degradation (PubMed:27941885)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
RHOBTB2 GTPase cycle
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 64

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE64 is an autosomal dominant form characterized by onset of seizures usually in the first year of life. Seizure types are variable and include focal dyscognitive and generalized tonic-clonic seizures, as well as febrile seizures in the mildest affected individuals. Seizures tend to respond to medical treatment.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
75.6 TPM
Córtex cerebral
63.2 TPM
Brain Frontal Cortex BA9
60.2 TPM
Brain Caudate basal ganglia
54.5 TPM
Brain Putamen basal ganglia
40.2 TPM
OUTRAS DOENÇAS (3)
developmental and epileptic encephalopathy, 64alternating hemiplegia of childhoodearly-infantile DEE
HGNC:18756UniProt:Q9BYZ6

Medicamentos e terapias

SODIUM OXYBATEPhase 1

Mecanismo: GABA-B receptor agonist

OXYBATEPhase 1

Mecanismo: GABA-B receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

895 variantes patogênicas registradas no ClinVar.

🧬 SLC1A3: GRCh38/hg38 5p13.3-11(chr5:30831208-46273389)x3 ()
🧬 SLC1A3: GRCh37/hg19 5p13.2(chr5:36259977-37805517)x1 ()
🧬 SLC1A3: NM_004172.5(SLC1A3):c.552A>G (p.Glu184=) ()
🧬 SLC1A3: NM_004172.5(SLC1A3):c.169G>A (p.Ala57Thr) ()
🧬 SLC1A3: NM_004172.5(SLC1A3):c.1003C>T (p.Leu335Phe) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 356 variantes classificadas pelo ClinVar.

196
160
Patogênica (55.1%)
VUS (44.9%)
VARIANTES MAIS SIGNIFICATIVAS
ATP1A3: NM_152296.5(ATP1A3):c.964G>A (p.Val322Ile) [Likely pathogenic]
ATP1A3: NM_152296.5(ATP1A3):c.2423C>T (p.Pro808Leu) [Pathogenic/Likely pathogenic]
ATP1A2: NM_000702.4(ATP1A2):c.2935_2936delinsAA (p.Pro979Lys) [Likely pathogenic]
ATP1A2: NM_000702.4(ATP1A2):c.36dup (p.Ala13fs) [Pathogenic]
CACNA1A: NM_001127222.2(CACNA1A):c.1914-2A>C [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
1Fase 12
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 2 medicamentos · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Hemiplegia alternante da infância

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

8 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
233 papers (10 anos)
#1

Parallels between bipolar disorder and ATP1A3-related diseases: a window into the investigation of lithium for alternating hemiplegia of childhood.

Orphanet journal of rare diseases2026 Feb 03

Alternating hemiplegia of childhood (AHC) shares many aspects with the psychiatric condition, bipolar disorder. AHC is a heterogeneous genetic disorder that can manifest in various fashions but will usually involve paroxysmal neuropsychiatric symptoms that are precipitated by environmental events or stressors, superimposed over developmental abnormalities of various severities. It occurs as a consequence of a variety of mutations of the alpha3 subunit of the sodium pump (ATP1A3). Treatment is generally symptomatic with flunarizine a nonselective calcium channel blocker, but other approaches have been attempted. Nonetheless, given the inadequate response of most patients, there continues to be a significant unmet need for adequate treatment approaches. Bipolar disorder, a severe psychiatric illness, also manifests with paroxysmal neuropsychiatric symptoms that are precipitated by environmental events or stressors. It is also characterized by significant dysfunction of the sodium pump. Lithium is an effective intervention for bipolar disorder and has never been utilized in AHC. Both bipolar disorder and AHC are associated with sodium pump dysfunction and increased intracellular sodium concentration. Both conditions respond to calcium channel blockers and the ketogenic diet. Lithium trials in AHC are warranted.

#2

Characterization of Sleep in Alternating Hemiplegia of Childhood: An International Survey.

Neurology. Genetics2026 Feb

Few studies have investigated sleep features in people with alternating hemiplegia of childhood (AHC). In this study, we present a bespoke survey of individuals with AHC to characterize sleep disturbances in this condition. A cross-sectional survey was disseminated through the UK and Italian AHC family associations, addressing their registered families with at least 1 child or adult with a confirmed diagnosis of AHC by their national reference centers and who had consented to be contacted by email. The entire questionnaire implemented in the online surveys was organized into 3 main sections and included the Pittsburgh Sleep Quality Index (PSQI) scale. This scale ranges from 0 to 21, with higher scores indicating poorer sleep quality. Internal consistency of the questionnaire was assessed using Cronbach alpha statistic. Forty-eight of 54 families with AHC (88.89%) filled out at least 1 item of the AHC-Sleep Questionnaire, and 36 of 54 (66.67%) completed the whole questionnaire. Eighteen of 44 people (40.91%) from our cohort reported having a problem with sleep, which was persistent for 10 of 44 (22.7%). Twenty-five of 44 people (56.82%) reported multiple arousals during a typical night, and for 9 of 25 (36%), these could be very prolonged. For 16 of 40 (40%) and 19 of 40 (47.5%), plegic spells resolved or improved, respectively, during sleep, whereas 5 of 40 (12.5%) reported no effect of sleep on these spells. The mean global PSQI score in 40 people was 5.40 (SD ± 4.69). Fifteen of 40 individuals (37.5%) had a global PSQI score ≥5. PSQI scores were significantly higher in those individuals who completed the questionnaire during summer (n = 6) compared with those who completed them during winter (n = 33) (p = 0.011, Mann-Whitney test). We found a strong correlation between AHC paroxysmal spell burden and PSQI score (Spearman r = 0.39, p < 0.01). The survey demonstrated a high degree of internal consistency, with a Cronbach alpha of 0.88 (95% CI 0.83-0.91). We dissected sleep issues and reported sleep disruption, including elevated global PSQI scores, in a significant proportion of individuals with AHC. The main implication of this study is the importance of conducting comprehensive and regular assessments of sleep in both children and adults with AHC.

#3

The Movement Disorder Spectrum of ATP1A3-Related Disorders: Cross-Sectional Analysis and Video Archive of 88 Patients.

Movement disorders : official journal of the Movement Disorder Society2026 Mar 18

ATP1A3-related disorders are characterized by genetic heterogeneity and phenotypic pleiotropy, posing significant challenges for classification. Although canonical phenotypes have traditionally guided decision-making, increasing evidence highlights their limitations in capturing the clinical complexity. The aims of this study were to characterize movement disorders, paroxysmal features, and genotype-phenotype relationships; to build a curated video archive; and to assess alignment with canonical phenotypes. This is an observational study of 88 individuals with pathogenic or likely pathogenic variants in ATP1A3 who were evaluated in specialized movement disorders programs. Age at last clinical follow-up ranged from 0.1 to 63 years; 80.7% were pediatric patients. Chronic movement disorders were present in 68 of 88 individuals (75%); most had two or more coexisting phenomenologies. Dystonia was most common (47/88, 53%), followed by spasticity (28/88, 32%) and ataxia (28/92, 32%). Paroxysmal events occurred in 78 of 88 (88%) patients, including dystonic spells (45/78, 58%), abnormal eye movements (39/78, 50%), and hemiplegic episodes (37/78, 47%). Common comorbidities included epilepsy (21/88, 24%), cognitive impairment (41/88, 47%), and neuropsychiatric disorders. Only 22 of 88 (25%) fulfilled criteria for a single canonical phenotype; 28 of 88 (32%) met canonical criteria plus additional features, 18 of 88 (20%) satisfied criteria for ≥2 canonical phenotypes, and 20 of 88 (23%) fit no canonical category. We identified 43 distinct ATP1A3 variants; recurrent variants (eg, p.Arg756His, p.Asp801Asn, p.Glu818Lys) showed variable expressivity across categories. The extensive clinical heterogeneity in ATP1A3-related disorders challenges rigid phenotypic classifications. The predominance of patients with overlapping or atypical features supports a shift toward flexible, symptom-based clinical approaches rather than strict reliance on canonical phenotype recognition. © 2026 International Parkinson and Movement Disorder Society.

#4

Unraveling Alternating Hemiplegia of Childhood: A Case Report with Genetic and Clinical Insights.

Case reports in neurology2025

Alternating hemiplegia of childhood (AHC) is a complex neurological disorder comprising paroxysmal episodes of repeated, transient paresis involving either or both sides of the body, with onset usually before the age of 18 months. The etiology is varied and includes channelopathy, mutations of the ATP1A3 gene that encode alpha subunit of the NA+-K+ ATPase pump. A 7-month-old girl presented with tonic neck deviation of the neck and eyes, episodic hemiparesis affecting both sides alternatively. Each episode resolved after sleep and was precipitated by hunger, fever, and sleep deprivation. Neurological examination and laboratory workup, including MRI and EEG, were normal. Whole-exome sequencing revealed a heterozygous de novo pathogenic mutation in the ATP1A3 gene (p.Asp801Asn), confirming AHC. She was started on flunarizine, a calcium channel blocker. Significant clinical improvement and catch-up in developmental milestones were observed on follow-up. AHC is frequently misdiagnosed due to its rarity and varied presentation. Diagnosis is clinical and supported by genetic testing. Mutations in ATP1A3 are common and often cluster at specific hotspots. Management includes symptomatic treatment and supportive care, with flunarizine offering some benefit. This case highlights the need for early recognition and genetic confirmation of AHC to initiate therapy and improve quality of life.

#5

Alternating Hemiplegia of Childhood and ATP1A3-Related Diseases: Insights From a Decade of Discovery and Collaboration.

Neurology. Genetics2025 Oct

This report presents key insights from the 2022 annual conference held in Edinburgh, commemorating the 10th anniversary of the discovery of ATP1A3 variants in alternating hemiplegia of childhood (AHC). This milestone event marked a decade of rapid advancements in research and clinical understanding, bringing together international experts and those with lived experience to reflect on progress, identify ongoing challenges, and shape the future of ATP1A3-related disease research. Over the past 10 years, our knowledge of ATP1A3-related diseases has expanded significantly, revealing a broader clinical spectrum, complex genotype-phenotype correlations, and novel pathophysiologic mechanisms. This symposium provided new data on cardiac and respiratory involvement in AHC, the impact of Na+, K+-ATPase dysfunction on neurodevelopment, and the evolving understanding of progressive disease trajectories. The conference also showcased emerging therapeutic strategies, including gene therapy, antisense oligonucleotides, and small-molecule interventions. This article synthesizes these discussions, offering a comprehensive overview of a decade of progress while highlighting the urgent need for continued collaboration. By integrating research, clinical expertise, and lived experience advocacy, the ATP1A3 community is paving the way for improved diagnosis, enhanced care, and the development of targeted treatments for these ultra-rare conditions.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC244 artigos no totalmostrando 197

2026

The Movement Disorder Spectrum of ATP1A3-Related Disorders: Cross-Sectional Analysis and Video Archive of 88 Patients.

Movement disorders : official journal of the Movement Disorder Society
2026

Parallels between bipolar disorder and ATP1A3-related diseases: a window into the investigation of lithium for alternating hemiplegia of childhood.

Orphanet journal of rare diseases
2025

CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.

Molecular syndromology
2026

Characterization of Sleep in Alternating Hemiplegia of Childhood: An International Survey.

Neurology. Genetics
2025

Paediatric retinal dystrophy associated with ATP1A3 in a child with a background of alternating hemiplegia of childhood.

Ophthalmic genetics
2025

Unraveling Alternating Hemiplegia of Childhood: A Case Report with Genetic and Clinical Insights.

Case reports in neurology
2025

Ketogenic diet for alternating hemiplegia of childhood: Case report and literature review.

Medicine
2025

Alternating Hemiplegia of Childhood and ATP1A3-Related Diseases: Insights From a Decade of Discovery and Collaboration.

Neurology. Genetics
2025

Clinical Improvement in a Case of Alternating Hemiplegia of Childhood After Cerebral Lymphatic Drainage.

International medical case reports journal
2025

Association of alcohol responsiveness and non-motor symptoms in isolated adult-onset dystonia.

Journal of neurology
2025

In vivo prime editing rescues alternating hemiplegia of childhood in mice.

Cell
2025

ADCY5-Mosaic Variants: A Diagnosis Not to Be Missed.

Movement disorders clinical practice
2025

Enhanced amygdala inhibitory neurotransmission and its vulnerability to hyperthermic stress in Atp1a2-deficient heterozygous mice.

Journal of neurophysiology
2025

Alternating hemiplegia of childhood associated mutations in Atp1a3 reveal diverse neurological alterations in mice.

Neurobiology of disease
2025

Practical management of repeated life-threatening status epilepticus in Alternating Hemiplegia of Childhood: Case report and literature review.

Epileptic disorders : international epilepsy journal with videotape
2025

The Vodka Trial: Clinical and Genetic Characteristics of Alcohol Responsiveness in Laryngeal Dystonia.

Movement disorders clinical practice
2025

Unusual Phenotypic Variability in Paroxysmal Dystonia Associated with Rare ATP1A3 Mutation: A Case Report and Review.

Journal of child neurology
2025

Pediatric paroxysmal movement disorders - A clinical epidemiological study in an Irish cohort.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2025

ATP1A3 Variants, Variably Penetrant Short QT Intervals, and Lethal Ventricular Arrhythmias.

JAMA pediatrics
2025

Critical Events in Patients With Alternating Hemiplegia of Childhood: A Cohort Study Subgroup Analysis.

AANA journal
2024

Oral ATP treatment in alternating hemiplegia of childhood: a case report and review.

Frontiers in medicine
2025

Imperatives and co-benefits of research into climate change and neurological disease.

Nature reviews. Neurology
2025

Progressive central cardiorespiratory rate downregulation and intensifying epilepsy lead to sudden unexpected death in epilepsy in mouse model of the most common human ATP1A3 mutation.

Epilepsia
2025

Alternating hemiplegia of childhood: challenges in a changing climate.

Nature reviews. Neurology
2024

Novel mouse model of alternating hemiplegia of childhood exhibits prominent motor and seizure phenotypes.

Neurobiology of disease
2025

Opsoclonus in Alternating Hemiplegia of Childhood Secondary to ATP1A3 p.Gly803Arg.

Movement disorders clinical practice
2025

Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta-analysis of an N-of-1 trial.

European journal of neurology
2024

A case of alternating hemiplegia in 2-month-old children with nystagmus as the first symptom: A case report.

Medicine
2024

Use of Botulinum Toxin in Upper-Limb Tremor: Systematic Review and Perspectives.

Toxins
2024

Children and Adolescent Patients with Variants in the ATP1A3 -encoded Sodium-Potassium ATPase Alpha-3 Subunit Demonstrate an Impaired QT Response to Bradycardia and Predisposition to Sinus Node Dysfunction.

medRxiv : the preprint server for health sciences
2024

Epilepsy with eyelid myoclonia in a patient with ATP1A3-related neurologic disorder.

Epileptic disorders : international epilepsy journal with videotape
2024

In vitro study of ATP1A3 p.Ala275Pro mutant causing alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism.

Frontiers in neuroscience
2024

Phenotype Distinctions in Mice Deficient in the Neuron-Specific α3 Subunit of Na,K-ATPase: Atp1a3tm1Ling/+ and Atp1a3 +/D801Y.

eNeuro
2024

Navigating the Complexity of Alternating Hemiplegia in Childhood: A Comprehensive Review.

Rambam Maimonides medical journal
2024

Alternating hemidystonia of childhood: a unique presentation of ATP1A3 treated with trihexyphenidyl.

Journal of neurology
2024

Is ethyl chloride the new nitrous oxide? A case report.

BMC neurology
2024

ATP1A3 regulates protein synthesis for mitochondrial stability under heat stress.

Disease models &amp; mechanisms
2024

Utilizing real-world evidence to investigate treatments in alternating hemiplegia of childhood: Implications for future trials in rare disease.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2024

Teaching Video NeuroImage: Oculomotor Abnormalities in Patients With Alternating Hemiplegia of Childhood.

Neurology
2024

Real life retrospective study of cannabidiol therapy in alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2024

Alternating hemiplegia of childhood misdiagnosed as hysteria: a case report.

Acta epileptologica
2024

Childhood-related neural genotype-phenotype in ATP1A3 mutations: comprehensive analysis.

Genes &amp; genomics
2024

Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene.

European journal of human genetics : EJHG
2024

Characteristics of non-sleep related apneas in children with alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

Alternating hemiplegia of childhood.

Handbook of clinical neurology
2024

Novel compound heterozygous ATP1A2 variants in a patient with fetal akinesia/hypokinesia sequence.

American journal of medical genetics. Part A
2023

Methodology of a Natural History Study of a Rare Neurodevelopmental Disorder: Alternating Hemiplegia of Childhood as a Prototype Disease.

Journal of child neurology
2024

Effect of Flunarizine on Recurrent Status Epilepticus in a Patient with Alternating Hemiplegia of Childhood.

Indian journal of pediatrics
2023

Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population.

Molecular genetics &amp; genomic medicine
2023

Brain structural changes in alternating hemiplegia of childhood using single-case voxel-based morphometry analysis.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2023

Development and testing of methods to record and follow up spells in patients with alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

Effect of Oxygen Administration on Paroxysmal Motor Events in Alternating Hemiplegia of Childhood.

Movement disorders : official journal of the Movement Disorder Society
2023

Epilepsy with eyelid myoclonia in the setting of de novo pathogenic variant in ATP1A3.

Epileptic disorders : international epilepsy journal with videotape
2023

The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients.

Brain &amp; development
2023

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.

Brain : a journal of neurology
2023

The CLDN5 gene at the blood-brain barrier in health and disease.

Fluids and barriers of the CNS
2023

De novo mutations in CLDN5: alternating hemiplegia of childhood or not?

Brain : a journal of neurology
2023

Oxygen Therapy: An Acute Treatment for Paroxysmal Dystonia in Alternating Hemiplegia of Childhood?

Movement disorders : official journal of the Movement Disorder Society
2023

A novel heterozygous ATP1A2 pathogenic variant in a Chinese child with MELAS-like alternating hemiplegia.

Molecular genetics &amp; genomic medicine
2023

Rare. The importance of research, analysis, reporting and education in 'solving' the genetic epilepsies: A perspective from the European patient advocacy group for EpiCARE.

European journal of medical genetics
2023

ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA.

European journal of pediatrics
2022

ATP1A3-Related Relapsing Encephalopathy with Cerebellar Ataxia (RECA): A Genetic Disorder with an Inflammatory Basis?

Movement disorders clinical practice
2022

Disease mutations of human α3 Na+/K+-ATPase define extracellular Na+ binding/occlusion kinetics at ion binding site III.

PNAS nexus
2023

Both Heterozygous and Homozygous Loss-of-Function JPH3 Variants Are Associated with a Paroxysmal Movement Disorder.

Movement disorders : official journal of the Movement Disorder Society
2022

The Phenotypic Continuum of ATP1A3-Related Disorders.

Neurology
2022

Alternating hemiplegia of childhood: An electroclinical study of sleep and hemiplegia.

PloS one
2023

ATP1A3-related early childhood onset developmental and epileptic encephalopathy responding to corpus callosotomy: A case report.

Brain &amp; development
2022

Molecular and clinical characteristics of ATP1A3-related diseases.

Frontiers in neurology
2022

Alternating hemiplegia of childhood: a distinct clinical entity and ATP1A3-related disorders: A narrative review.

Medicine
2022

Anesthetic Implications in Alternating Hemiplegia of Childhood: A Case Report.

AANA journal
2022

The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy.

Clinical neurophysiology practice
2022

Recurrent de novo mutations in CLDN5 induce an anion-selective blood-brain barrier and alternating hemiplegia.

Brain : a journal of neurology
2022

Hemidystonia with polymicrogyria is part of ATP1A3-related disorders.

Brain &amp; development
2022

[Alternating Hemiplegia of Childhood associated with a pathogenic variant of the ATP1A3 gene].

Andes pediatrica : revista Chilena de pediatria
2022

Autonomic risks in Alternating Hemiplegia of Childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2022

Characterization of sedation and anesthesia complications in patients with alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2022

A novel presentation of an ATP1A3 gene mutation - case report and literature review.

European review for medical and pharmacological sciences
2022

Alternating Hemiplegia of Childhood: neurological comorbidities and intrafamilial variability.

Italian journal of pediatrics
2022

Non-Stationary Outcome of Alternating Hemiplegia of Childhood into Adulthood.

Movement disorders clinical practice
2021

A Rare Cause of Recurrent Febrile Encephalopathy in a Child: The Expanding Spectrum of ATP1A3 Mutations.

Cureus
2022

Alternating Hemiplegia of Childhood in a Child Harboring a Novel TBC1D24 Mutation: Case Report and Literature Review.

Neuropediatrics
2022

Progression of alternating hemiplegia of childhood-related focal epilepsy to electrical status epilepticus in sleep with reversible encephalopathy.

Epileptic disorders : international epilepsy journal with videotape
2022

Different phenotypes of neurological diseases, including alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism, caused by de novo ATP1A3 mutation in a family.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2021

Long-Term Follow-Up of a Patient with a De Novo p.Arg769Cys Mutation in the ATP1A3 Gene.

Movement disorders clinical practice
2021

Expanding Phenotype of ATP1A3 - Related Disorders: A Case Series.

Child neurology open
2021

Genetically altered animal models for ATP1A3-related disorders.

Disease models &amp; mechanisms
2021

ATP1A3-related disorders in the differential diagnosis of acute brainstem and cerebellar dysfunction.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2021

ATP1A3-Encoded Sodium-Potassium ATPase Subunit Alpha 3 D801N Variant Is Associated With Shortened QT Interval and Predisposition to Ventricular Fibrillation Preceded by Bradycardia.

Journal of the American Heart Association
2021

Variable Phenotypes in Alternating Hemiplegia of Childhood: A Genetically Proven Case Series.

Annals of Indian Academy of Neurology
2021

An 88.8-kb Novel Deletion of 19q13.2 Encompassing the ATP1A3 Gene Detected by Array CGH in a Patient with Delayed Psychomotor Development, Generalized Hypotonia and Macrocephaly.

Molecular syndromology
2021

Alternating hemiplegia of childhood: evolution over time and mouse model corroboration.

Brain communications
2021

Variants of ATP1A3 in residue 756 cause a separate phenotype of relapsing encephalopathy with cerebellar ataxia (RECA)-Report of two cases and literature review.

Molecular genetics &amp; genomic medicine
2021

Alternating Hemiplegia of Childhood Caused by ATP1A3 Mutations: A Report of Two Cases.

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
2021

A case report of atypical hemiplegic migraine with nonheadache onset in a Chinese child.

BMC neurology
2021

Alternating Hemiplegia of Childhood: A Series of Genetically Confirmed Four Cases from Southern India with Review of Published Literature.

Journal of pediatric genetics
2021

Revision of the diagnostic criteria of alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2021

Alternating Hemiplegia of Childhood: Genotype-Phenotype Correlations in a Cohort of 39 Italian Patients.

Frontiers in neurology
2021

ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.

Brain : a journal of neurology
2021

ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum.

Frontiers in neurology
2021

[Alternating hemiplegia with epilepsy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2021

De novo ATP1A2 variants in two Chinese children with alternating hemiplegia of childhood upgraded the gene-disease relationship and variant classification: a case report.

BMC medical genomics
2021

De novo ATP1A3 variants cause polymicrogyria.

Science advances
2021

Hypothalamic-pituitary dysfunction in alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2021

Alternating hemiplegia of childhood presenting as recurrent apnoea in a term newborn infant.

Annals of the Academy of Medicine, Singapore
2021

Novel presentations associated with a PDHA1 variant - Alternating hemiplegia in Hemizygote proband and Guillain Barre Syndrome in Heterozygote mother.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2021

A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2021

Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3Mashl/+, Mouse Model of Alternating Hemiplegia of Childhood.

Human gene therapy
2021

[Professor WU Xu's clinical experience of acupuncture for alternating hemiplegia of childhood].

Zhongguo zhen jiu = Chinese acupuncture &amp; moxibustion
2021

RHOBTB2 Mutations Expand the Phenotypic Spectrum of Alternating Hemiplegia of Childhood.

Neurology
2021

Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations.

Epilepsy &amp; behavior : E&amp;B
2021

Rapid-onset dystonia-parkinsonism with ATP1A3 mutation and left lower limb paroxysmal dystonia.

Brain &amp; development
2021

Intravenous Immunoglobulin in the Treatment of Alternating Hemiplegia of Childhood.

Clinical neuropharmacology
2020

Effect of Flunarizine on Alternating Hemiplegia of Childhood in a Patient with the p.E815K Mutation in ATP1A3: A Case Report.

Case reports in neurology
2020

Gross Motor Function Disorders in Patients with Alternating Hemiplegia of Childhood.

Journal of mother and child
2020

Characterization of Severe and Extreme Behavioral Problems in Patients With Alternating Hemiplegia of Childhood.

Pediatric neurology
2020

Cardiac phenotype in ATP1A3-related syndromes: A multicenter cohort study.

Neurology
2020

Alternating Hemiplegia of Childhood: gastrointestinal manifestations and correlation with neurological impairments.

Orphanet journal of rare diseases
2020

Comparative analysis of alternating hemiplegia of childhood and rapid-onset dystonia-parkinsonism ATP1A3 mutations reveals functional deficits, which do not correlate with disease severity.

Neurobiology of disease
2020

Alternating Hemiplegia of Childhood in Korea: a Case Report.

Journal of Korean medical science
2020

The epileptology of alternating hemiplegia of childhood.

Neurology
2020

Molecular genetic and mitochondrial metabolic analyses confirm the suspected mitochondrial etiology in a pediatric patient with an atypical form of alternating hemiplegia of childhood.

Molecular genetics and metabolism reports
2020

Long-term follow-up and novel genotype-phenotype analysis of monozygotic twins with ATP1A3 mutation in Alternating Hemiplegia of Childhood-2.

European journal of medical genetics
2020

Brain volumetrics in alternating hemiplegia of childhood.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2020

Neuronal modeling of alternating hemiplegia of childhood reveals transcriptional compensation and replicates a trigger-induced phenotype.

Neurobiology of disease
2020

Mutational and phenotypic expansion of ATP1A3-related disorders: Report of nine cases.

Gene
2020

[Alternating hemiplegia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2020

Alternating Hemiplegia of Childhood: Understanding the Genotype-Phenotype Relationship of ATP1A3 Variations.

The application of clinical genetics
2020

Movement disorders in patients with alternating hemiplegia: "Soft" and "stiff" at the same time.

Neurology
2020

Non-motor symptoms in movement disorders: more than meets the eye.

Developmental medicine and child neurology
2020

Magnetic resonance imaging volumetric analysis in patients with Alternating hemiplegia of childhood: A pilot study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2020

Epileptic encephalopathy with features of rapid-onset dystonia Parkinsonism and alternating hemiplegia of childhood: a novel combination phenotype associated with ATP1A3 mutation.

Epileptic disorders : international epilepsy journal with videotape
2020

Social impairments in alternating hemiplegia of childhood.

Developmental medicine and child neurology
2020

Ketamine Infusion for Super Refractory Status Epilepticus in Alternating Hemiplegia of Childhood.

Neuropediatrics
2020

ATP1A3-related epilepsy: Report of seven cases and literature-based analysis of treatment response.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2020

White matter and cerebellar involvement in alternating hemiplegia of childhood.

Journal of neurology
2020

Clinical and Genetic Spectrum of ATP1A3-Related Disorders in a Korean Pediatric Population.

Journal of clinical neurology (Seoul, Korea)
2020

Management of Alternating Hemiplegia of Childhood: A Review.

Pediatric neurology
2020

Recurrent Episodes of Hypotonia, Encephalopathy, and Quadriparesis in a 3-Year-Old Female.

Clinical pediatrics
2019

A novel lethal recognizable polymicrogyric syndrome caused by ATP1A2 homozygous truncating variants.

Brain : a journal of neurology
2019

Alternating hemiplegia and paroxysmal torticollis caused by SCN4A mutation: A new phenotype?

Neurology
2019

Monocular nystagmus in a patient with alternating hemiplegia of childhood.

Neurology
2019

Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition.

Neurobiology of disease
2019

Fever-related ataxia: a case report of CAPOS syndrome.

Cerebellum &amp; ataxias
2019

Revising rapid-onset dystonia-parkinsonism: Broadening indications for ATP1A3 testing.

Movement disorders : official journal of the Movement Disorder Society
2019

Physical Therapy for a Patient With Alternating Hemiplegia of Childhood: A Case Report.

Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association
2019

Heart rate variability in a patient with alternating hemiplegia.

Intractable &amp; rare diseases research
2019

Alternating Hemiplegia of Childhood in a Person of Malay Ethnicity with Diffusion Tensor Imaging Abnormalities.

Journal of movement disorders
2019

An Option to Consider for Alternating Hemiplegia of Childhood: Aripiprazole.

Clinical neuropharmacology
2019

ATP1A3 mosaicism in families with alternating hemiplegia of childhood.

Clinical genetics
2019

Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2019

Alternating hemiplegia of childhood: First South African case report and verapamil as a possible treatment option.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
2020

Biallelic loss of function variants in ATP1A2 cause hydrops fetalis, microcephaly, arthrogryposis and extensive cortical malformations.

European journal of medical genetics
2019

A recurrent de novo mutation in ATP1A3 gene in a Mexican patient with alternating hemiplegia of childhood detected by massively parallel sequencing.

Boletin medico del Hospital Infantil de Mexico
2019

Homozygous TANGO2 Single Nucleotide Variants Presenting with Additional Manifestations Resembling Alternating Hemiplegia of Childhood-Expanding the Phenotype of a Recently Reported Condition.

Neuropediatrics
2019

Polysomnography Findings and Sleep Disorders in Children With Alternating Hemiplegia of Childhood.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
2018

Alternating Hemiplegia of Childhood in Two Adult Patients with a Mild Syndrome.

Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology
2020

Cell biology and dynamics of Neuronal Na+/K+-ATPase in health and diseases.

Neuropharmacology
2019

Alternating hemiplegia of childhood: the gap between paroxysmal manifestations and non-paroxysmal characteristics.

Developmental medicine and child neurology
2018

A novel ATP1A2 mutation in a patient with hypokalaemic periodic paralysis and CNS symptoms.

Brain : a journal of neurology
2019

A case of early onset life-threatening epilepsy associated with a novel ATP1A3 gene variant.

Brain &amp; development
2018

[Genotype-phenotype correlation in patients with alternating hemiplegia of childhood].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2019

Cognitive, adaptive, and behavioral profiles and management of alternating hemiplegia of childhood.

Developmental medicine and child neurology
2018

Comorbidities of Rare Epilepsies: Results from the Rare Epilepsy Network.

The Journal of pediatrics
2018

Benign nocturnal alternating hemiplegia of childhood: A clinical and nomenclatural reappraisal.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2018

Novel E815K knock-in mouse model of alternating hemiplegia of childhood.

Neurobiology of disease
2018

Early Life Epilepsy and Episodic Apnea Revealing an ATP1A3 Mutation: Report of a Pediatric Case and Literature Review.

Neuropediatrics
2018

Pearls & Oy-sters: Alternating hemiplegia of childhood mimics focal epilepsy and paroxysmal dyskinesia in infancy.

Neurology
2018

De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome.

Molecular genetics and metabolism reports
2020

Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia.

Molecular psychiatry
2018

Mechanisms of increased hippocampal excitability in the Mashl+/- mouse model of Na+ /K+ -ATPase dysfunction.

Epilepsia
2018

Early-onset encephalopathy with paroxysmal movement disorders and epileptic seizures without hemiplegic attacks: About three children with novel ATP1A3 mutations.

Brain &amp; development
2018

Variants in the ATP1A3 Gene Mutations within Severe Apnea Starting in Early Infancy: An Observational Study of Two Cases with a Possible Relation to Epileptic Activity.

Neuropediatrics
2018

Further characterization of CAPOS/CAOS syndrome with the Glu818Lys mutation in the ATP1A3 gene: A case report.

Brain &amp; development
2017

Alternating hemiplegia of childhood: Clinical case and video description.

Neurology. Clinical practice
2018

Clinical Benefit of NMDA Receptor Antagonists in a Patient With ATP1A2 Gene Mutation.

Pediatrics
2018

Direct evidence of impaired neuronal Na/K-ATPase pump function in alternating hemiplegia of childhood.

Neurobiology of disease
2018

Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations.

Cerebellum (London, England)
2018

ATP1A3 spectrum disorders: A video-documented history of 7 genetically confirmed early onset cases.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2018

Recurrent Focal Seizures and Transient Hemiparesis: Think About Alternating Hemiplegia of Childhood.

Pediatric neurology
2018

ATP1A3-related epileptic encephalopathy responding to ketogenic diet.

Brain &amp; development
2018

The CAPOS mutation in ATP1A3 alters Na/K-ATPase function and results in auditory neuropathy which has implications for management.

Human genetics
2018

ATP1A3-related disorders: An update.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2018

Long-term follow up of an adult with alternating hemiplegia of childhood and a p.Gly755Ser mutation in the ATP1A3 gene.

Brain &amp; development
2018

A de novo p.Arg756Cys mutation in ATP1A3 causes a distinct phenotype with prolonged weakness and encephalopathy triggered by fever.

Brain &amp; development
2017

Disruption of Ankyrin B and Caveolin-1 Interaction Sites Alters Na+,K+-ATPase Membrane Diffusion.

Biophysical journal
2017

A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.

Orphanet journal of rare diseases
2017

More Than a Decade of Misdiagnosis of Alternating Hemiplegia of Childhood with Catastrophic Outcome.

Case reports in medicine
2017

[Diagnosis of alternating hemiplegia of childhood].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2017

[Alternating hemiplegia of childhood and epilepsy in an infant].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2017

An Infant With Epilepsy and Recurrent Hemiplegia due to Compound Heterozygous Variants in ATP1A2.

Pediatric neurology
2017

Assessment of acute motor deficit in the pediatric emergency room.

Jornal de pediatria
2017

ATP1A3 mutant patient with alternating hemiplegia of childhood and brain spectroscopic abnormalities.

Journal of the neurological sciences
2017

Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation.

Pediatric neurology
2017

Alternating hemiplegia of childhood and a pathogenic variant of ATP1A3: a case report and pathophysiological considerations.

Epileptic disorders : international epilepsy journal with videotape
2017

Challenges describing motor profiles in alternating hemiplegia of childhood.

Developmental medicine and child neurology
2017

Motor function domains in alternating hemiplegia of childhood.

Developmental medicine and child neurology
2017

Topiramate Therapy in Alternating Hemiplegia of Childhood.

Indian journal of pediatrics
Ver todos os 244 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Hemiplegia alternante da infância.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Hemiplegia alternante da infância

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Parallels between bipolar disorder and ATP1A3-related diseases: a window into the investigation of lithium for alternating hemiplegia of childhood.
    Orphanet journal of rare diseases· 2026· PMID 41634807mais citado
  2. Characterization of Sleep in Alternating Hemiplegia of Childhood: An International Survey.
    Neurology. Genetics· 2026· PMID 41473933mais citado
  3. The Movement Disorder Spectrum of ATP1A3-Related Disorders: Cross-Sectional Analysis and Video Archive of 88 Patients.
    Movement disorders : official journal of the Movement Disorder Society· 2026· PMID 41850905mais citado
  4. Unraveling Alternating Hemiplegia of Childhood: A Case Report with Genetic and Clinical Insights.
    Case reports in neurology· 2025· PMID 41322064mais citado
  5. Alternating Hemiplegia of Childhood and ATP1A3-Related Diseases: Insights From a Decade of Discovery and Collaboration.
    Neurology. Genetics· 2025· PMID 41048925mais citado
  6. D801N in ATP1A3-encoded Na/K-ATPase alpha 3 causes cardiac arrhythmogenesis through sodium-calcium exchanger-mediated calcium overload.
    JCI Insight· 2026· PMID 41948929recente
  7. CAPOS and Beyond: ATP1A3 Variants in Pediatric Movement Disorders - Case Reports.
    Mol Syndromol· 2025· PMID 41480049recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2131(Orphanet)
  2. MONDO:0016241(MONDO)
  3. GARD:11(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q2632848(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Hemiplegia alternante da infância

ORPHA:2131 · MONDO:0016241
Prevalência
Unknown
Herança
Autosomal dominant, Not applicable
CID-10
G98 · Outros transtornos do sistema nervoso não classificados em outra parte
CID-11
Medicamentos
2 registrados
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0338488
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades